Navellier & Associates’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,840
Closed -$208K 364
2024
Q4
$208K Sell
7,840
-6,778
-46% -$180K 0.02% 313
2024
Q3
$423K Hold
14,618
0.06% 240
2024
Q2
$409K Hold
14,618
0.05% 267
2024
Q1
$406K Hold
14,618
0.05% 265
2023
Q4
$421K Sell
14,618
-5,872
-29% -$169K 0.06% 241
2023
Q3
$680K Buy
+20,490
New +$680K 0.12% 175
2021
Q1
Sell
-59,162
Closed -$2.18M 311
2020
Q4
$2.18M Sell
59,162
-6,770
-10% -$249K 0.39% 84
2020
Q3
$2.3M Sell
65,932
-5,468
-8% -$190K 0.5% 71
2020
Q2
$2.22M Sell
71,400
-4,215
-6% -$131K 0.53% 65
2020
Q1
$2.34M Sell
75,615
-6,472
-8% -$200K 0.55% 45
2019
Q4
$3.05M Buy
82,087
+1,542
+2% +$57.3K 0.49% 57
2019
Q3
$2.75M Buy
80,545
+5,658
+8% +$193K 0.45% 59
2019
Q2
$3.08M Buy
74,887
+2,019
+3% +$83K 0.48% 55
2019
Q1
$2.94M Sell
72,868
-248
-0.3% -$9.99K 0.46% 61
2018
Q4
$3.03M Buy
73,116
+513
+0.7% +$21.2K 0.51% 41
2018
Q3
$3.04M Sell
72,603
-223
-0.3% -$9.33K 0.39% 74
2018
Q2
$2.51M Buy
72,826
+1,095
+2% +$37.7K 0.35% 87
2018
Q1
$2.42M Buy
71,731
+60,905
+563% +$2.05M 0.37% 81
2017
Q4
$372K Buy
10,826
+447
+4% +$15.4K 0.07% 209
2017
Q3
$352K Sell
10,379
-414
-4% -$14K 0.07% 178
2017
Q2
$344K Sell
10,793
-280
-3% -$8.92K 0.05% 233
2017
Q1
$359K Buy
11,073
+749
+7% +$24.3K 0.05% 225
2016
Q4
$318K Sell
10,324
-644
-6% -$19.8K 0.05% 218
2016
Q3
$352K Buy
10,968
+4,225
+63% +$136K 0.05% 190
2016
Q2
$225K Buy
+6,743
New +$225K 0.03% 217
2014
Q1
Sell
-7,322
Closed -$213K 342
2013
Q4
$213K Buy
+7,322
New +$213K 0.01% 298